Search clinical trials for: Olorofim
Total 20 results
-
F2G Biotech GmbHCovanceCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHCovanceCompleted
-
F2G Biotech GmbHPRA Health SciencesCompletedInvasive Fungal InfectionsNetherlands
-
F2G Biotech GmbHCompletedHepatic ImpairmentUnited States
-
F2G Biotech GmbHHammersmith Medicines ResearchCompleted
-
F2G Biotech GmbHQuotient ClinicalWithdrawnInvasive Aspergillosis
-
F2G Biotech GmbHCompletedRenal ImpairmentUnited States
-
F2G Biotech GmbHIqvia Pty LtdRecruitingInvasive Fungal InfectionsUnited States, Netherlands, Israel, Spain, Korea, Republic of, Belgium, Australia, Germany, France, Brazil, Poland, Egypt, Russian Federation, Thailand, Turkey, United Kingdom, Vietnam
-
F2G Biotech GmbHSimbec ResearchCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHIqvia Pty Ltd; ShionogiRecruitingInvasive AspergillosisUnited States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
F2G Biotech GmbHUniversity Hospital of CologneWithdrawnAcute Myeloid Leukemia | Pulmonary Aspergillosis - Invasive
-
F2G Biotech GmbHQuotient ClinicalCompleted
-
F2G Biotech GmbHSimbec-Orion GroupCompleted
-
F2G Biotech GmbHHammersmith Medicines ResearchCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHCelerion LtdCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHBio-Kinetic Europe, Ltd.WithdrawnInvasive Aspergillosis
-
F2G Biotech GmbHThe Clinical Trials Centre Cologne; Klinik für Hämatologie, Aachen; Medizinische...Withdrawn
-
F2G Biotech GmbHSimbecRresearch Ltd.CompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHHammersmith Medicines ResearchCompleted